COO
HealthcareThe Cooper Companies, Inc.
$82.74
+$1.63 (+2.01%)
Jan 5, 2026
Price History (1Y)
Analysis
The Cooper Companies, Inc. is a healthcare company operating in the medical instruments and supplies industry. With a market capitalization of $16.45 billion, the company has a significant presence in its sector, employing 15,000 individuals worldwide. Financially, The Cooper Companies demonstrates moderate profitability, with gross margin standing at 65.5% and operating margin at 13.5%. Net income for the trailing twelve months amounts to $374.90 million, while earnings before interest, taxes, depreciation, and amortization (EBITDA) totals $1.06 billion. The company's return on equity (ROE) is 4.6%, and its return on assets (ROA) is 3.5%. From a balance sheet perspective, the company maintains a debt-to-equity ratio of 33.78 and holds cash reserves of $110.60 million. Valuation metrics suggest that The Cooper Companies trades at a premium. With a price-to-earnings ratio (P/E) of 43.32 for the trailing twelve months and 16.74 on a forward basis, the company's valuation is elevated compared to other industry peers. Revenue growth over the past year has been moderate, at 4.6%, while earnings growth has contracted by 28.2% over the same period. The company pays out no dividends, as indicated by a payout ratio of 0.0%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About The Cooper Companies, Inc.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Visit website →Key Statistics
- Market Cap
- $16.45B
- P/E Ratio
- 43.32
- 52-Week High
- $100.24
- 52-Week Low
- $61.78
- Avg Volume
- 2.78M
- Beta
- 1.03
Company Info
- Industry
- Medical Instruments & Supplies
- Exchange
- NMS
- Country
- United States
- Employees
- 15,000